These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 29052617)

  • 21. OROS-methylphenidate efficacy on specific executive functioning deficits in adults with ADHD: a randomized, placebo-controlled cross-over study.
    Bron TI; Bijlenga D; Boonstra AM; Breuk M; Pardoen WF; Beekman AT; Kooij JJ
    Eur Neuropsychopharmacol; 2014 Apr; 24(4):519-28. PubMed ID: 24508533
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Methylphenidate does not influence smoking-reinforced responding or attentional performance in adult smokers with and without attention deficit hyperactivity disorder (ADHD).
    Kollins SH; Schoenfelder E; English JS; McClernon FJ; Dew RE; Lane SD
    Exp Clin Psychopharmacol; 2013 Oct; 21(5):375-84. PubMed ID: 24099358
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased default-mode variability is related to reduced task-performance and is evident in adults with ADHD.
    Mowinckel AM; Alnæs D; Pedersen ML; Ziegler S; Fredriksen M; Kaufmann T; Sonuga-Barke E; Endestad T; Westlye LT; Biele G
    Neuroimage Clin; 2017; 16():369-382. PubMed ID: 28861338
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Better efficacy for the osmotic release oral system methylphenidate among poor adherents to immediate-release methylphenidate in the three ADHD subtypes.
    Chou WJ; Chou MC; Tzang RF; Hsu YC; Gau SS; Chen SJ; Wu YY; Huang YF; Liang HY; Cheng H
    Psychiatry Clin Neurosci; 2009 Apr; 63(2):167-75. PubMed ID: 19335386
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Smoking withdrawal symptoms are more severe among smokers with ADHD and independent of ADHD symptom change: results from a 12-day contingency-managed abstinence trial.
    McClernon FJ; Van Voorhees EE; English J; Hallyburton M; Holdaway A; Kollins SH
    Nicotine Tob Res; 2011 Sep; 13(9):784-92. PubMed ID: 21571687
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Abstinence-induced withdrawal severity among adolescent smokers with and without ADHD: disentangling effects of nicotine and smoking reinstatement.
    Bidwell LC; Balestrieri SG; Colby SM; Knopik VS; Tidey JW
    Psychopharmacology (Berl); 2018 Jan; 235(1):169-178. PubMed ID: 29018894
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anxiety and Depressed Mood Decline Following Smoking Abstinence in Adult Smokers with Attention Deficit Hyperactivity Disorder.
    Covey LS; Hu MC; Winhusen T; Lima J; Berlin I; Nunes E
    J Subst Abuse Treat; 2015 Dec; 59():104-8. PubMed ID: 26272693
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Drug-specific laterality effects on frontal lobe activation of atomoxetine and methylphenidate in attention deficit hyperactivity disorder boys during working memory.
    Cubillo A; Smith AB; Barrett N; Giampietro V; Brammer M; Simmons A; Rubia K
    Psychol Med; 2014 Feb; 44(3):633-46. PubMed ID: 23597077
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of smoking abstinence on reaction time variability in smokers with and without ADHD: an ex-Gaussian analysis.
    Kollins SH; McClernon FJ; Epstein JN
    Drug Alcohol Depend; 2009 Feb; 100(1-2):169-72. PubMed ID: 19041198
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Methylphenidate does not improve interference control during a working memory task in young patients with attention-deficit hyperactivity disorder.
    Prehn-Kristensen A; Krauel K; Hinrichs H; Fischer J; Malecki U; Schuetze H; Wolff S; Jansen O; Duezel E; Baving L
    Brain Res; 2011 May; 1388():56-68. PubMed ID: 21385569
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Methylphenidate enhances cognitive performance in adults with poor baseline capacities regardless of attention-deficit/hyperactivity disorder diagnosis.
    Agay N; Yechiam E; Carmel Z; Levkovitz Y
    J Clin Psychopharmacol; 2014 Apr; 34(2):261-5. PubMed ID: 24525641
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of computerized cognitive training as add-on treatment to stimulants in ADHD: a pilot fMRI study.
    de Oliveira Rosa V; Rosa Franco A; Abrahão Salum Júnior G; Moreira-Maia CR; Wagner F; Simioni A; de Fraga Bassotto C; R Moritz G; Schaffer Aguzzoli C; Buchweitz A; Schmitz M; Rubia K; Paim Rohde LA
    Brain Imaging Behav; 2020 Oct; 14(5):1933-1944. PubMed ID: 31218531
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Selective effects of methylphenidate in attention deficit hyperactivity disorder: a functional magnetic resonance study.
    Vaidya CJ; Austin G; Kirkorian G; Ridlehuber HW; Desmond JE; Glover GH; Gabrieli JD
    Proc Natl Acad Sci U S A; 1998 Nov; 95(24):14494-9. PubMed ID: 9826728
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Electrophysiological effects of stimulant treatment on inhibitory control in children with attention-deficit/hyperactivity disorder.
    Pliszka SR; Liotti M; Bailey BY; Perez R; Glahn D; Semrud-Clikeman M
    J Child Adolesc Psychopharmacol; 2007 Jun; 17(3):356-66. PubMed ID: 17630869
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Smoking withdrawal shifts the spatiotemporal dynamics of neurocognition.
    Kozink RV; Lutz AM; Rose JE; Froeliger B; McClernon FJ
    Addict Biol; 2010 Oct; 15(4):480-90. PubMed ID: 21040240
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of Methylphenidate Hydrochloride Extended-Release Capsules (Aptensio XR™) in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: A Phase III, Randomized, Double-Blind Study.
    Wigal SB; Nordbrock E; Adjei AL; Childress A; Kupper RJ; Greenhill L
    CNS Drugs; 2015 Apr; 29(4):331-40. PubMed ID: 25877989
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dissociation in response to methylphenidate on response variability in a group of medication naïve children with ADHD.
    Johnson KA; Barry E; Bellgrove MA; Cox M; Kelly SP; Dáibhis A; Daly M; Keavey M; Watchorn A; Fitzgerald M; McNicholas F; Kirley A; Robertson IH; Gill M
    Neuropsychologia; 2008 Apr; 46(5):1532-41. PubMed ID: 18289615
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Striatal Activation Predicts Differential Therapeutic Responses to Methylphenidate and Atomoxetine.
    Schulz KP; Bédard AV; Fan J; Hildebrandt TB; Stein MA; Ivanov I; Halperin JM; Newcorn JH
    J Am Acad Child Adolesc Psychiatry; 2017 Jul; 56(7):602-609.e2. PubMed ID: 28647012
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinically-oriented monitoring of acute effects of methylphenidate on cerebral hemodynamics in ADHD children using fNIRS.
    Monden Y; Dan H; Nagashima M; Dan I; Kyutoku Y; Okamoto M; Yamagata T; Momoi MY; Watanabe E
    Clin Neurophysiol; 2012 Jun; 123(6):1147-57. PubMed ID: 22088661
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Verbal working memory-related functional connectivity alterations in boys with attention-deficit/hyperactivity disorder and the effects of methylphenidate.
    Wu ZM; Bralten J; An L; Cao QJ; Cao XH; Sun L; Liu L; Yang L; Mennes M; Zang YF; Franke B; Hoogman M; Wang YF
    J Psychopharmacol; 2017 Aug; 31(8):1061-1069. PubMed ID: 28656805
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.